Teleophthalmology for Diabetic Retinopathy
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment I-SITE Intervention, Usual Care Teleophthalmology for diabetic retinopathy?
Research shows that teleophthalmology, which uses technology to screen for eye diseases like diabetic retinopathy, is effective in identifying these conditions in various settings, such as rural areas in Alberta and Kenya. This approach allows for early detection and management without needing in-person visits, making it a practical and efficient option for patients.12345
How is the I-SITE Intervention treatment for diabetic retinopathy unique?
The I-SITE Intervention uses teleophthalmology, which allows for remote screening and monitoring of diabetic retinopathy, making it accessible for patients in rural or underserved areas. This approach differs from traditional in-person eye exams by using digital imaging to assess eye health, potentially increasing early detection and treatment opportunities.14678
What is the purpose of this trial?
This study is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in urban, multi-payer health systems.
Research Team
Yao Liu, MD, MS
Principal Investigator
UW School of Medicine and Public Health
Eligibility Criteria
This trial is for individuals with type 1 or type 2 diabetes who are part of an urban health system and have had diabetic eye screenings. Participants' medical records must include specific ICD-10 codes for diabetes and billing data for teleophthalmology services.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Usual Care Teleophthalmology
All sites receive usual care teleophthalmology with access to the I-SITE online toolkit and use of non-mydriatic retinal cameras for diabetic eye screening.
I-SITE Intervention
Implementation of the I-SITE program including webinars, in-person meetings, and teleconferences to integrate teleophthalmology into primary care workflows.
Follow-up
Participants are monitored for changes in diabetic screening rates and follow-up rates for in-person eye care.
Treatment Details
Interventions
- I-SITE Intervention
- Usual Care Teleophthalmology
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Eye Institute (NEI)
Collaborator